Medical Data Dilemma: UK Reviews Palantir Contract Amid AI Deployment in Clinics

The collection of biomedical data is becoming the most toxic zone for IT corporations. On June 9, 2026, the UK government initiated a strict audit of the National Health Service (NHS) contract with American company Palantir, worth £330 million.

This event unfolds against the backdrop of the global `Philips Future Health Index` report release, which dryly noted: AI implementation is already critically saving doctors' time and saving lives, but scaling is hampered by data fragmentation. The British precedent reveals the reason for this slowdown. Society is deeply afraid of handing over sensitive health records to the control of transnational companies known for their ties to intelligence agencies (as in the case of Peter Thiel's Palantir). MedTech development has hit a crisis of trust: authorities are trying to find a balance between the efficiency of machine learning and protecting the medical sovereignty of citizens.

Source: UK Parliament / Philips / BMJ / Reuters